{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:47:32Z","timestamp":1774961252623,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejphar.2019.172473","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T11:07:59Z","timestamp":1560942479000},"page":"172473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["New insight into systemic mastocytosis mediated by cytokines IL-1\u03b2 and IL-33: Potential inhibitory effect of IL-37"],"prefix":"10.1016","volume":"858","author":[{"given":"Pio","family":"Conti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorina","family":"Lauritano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Caraffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Enrica","family":"Gallenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros K.","family":"Kritas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpaolo","family":"Ronconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Pandolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejphar.2019.172473_bib1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJM199202273260912","article-title":"Systemic mastocytosis","volume":"326","author":"Austen","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172473_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ad.2015.09.009","article-title":"Update on mastocytosis (Part 2): categories, prognosis, and treatment","volume":"107","author":"Aza\u00f1a","year":"2016","journal-title":"Actas Dermosifiliogr"},{"issue":"37","key":"10.1016\/j.ejphar.2019.172473_bib3","doi-asserted-by":"crossref","first-page":"14224","DOI":"10.1074\/jbc.RA118.003698","article-title":"Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue","volume":"293","author":"Ballak","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172473_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000315946","article-title":"Mastocytosis","volume":"95","author":"Brockow","year":"2010","journal-title":"Chem. Immunol. Allergy"},{"issue":"3","key":"10.1016\/j.ejphar.2019.172473_bib5","first-page":"449","article-title":"New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators","volume":"32","author":"Caraffa","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"1","key":"10.1016\/j.ejphar.2019.172473_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/imr.12605","article-title":"Suppression of inflammation and acquired immunity by IL-37","volume":"281","author":"Cavalli","year":"2018","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172473_bib7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1073\/pnas.1523212113","article-title":"Beneficial effects of IL-37 after spinal cord injury in mice","volume":"113","author":"Coll-Mir\u00f3","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ejphar.2019.172473_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.autrev.2006.08.015","article-title":"Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32)","volume":"6","author":"Conti","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172473_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12475","article-title":"Critical role of inflammatory mast cell in fibrosis: potential therapeutic effect of IL-37","volume":"51","author":"Conti","year":"2018","journal-title":"Cell Prolif"},{"issue":"9","key":"10.1016\/j.ejphar.2019.172473_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00011-018-1166-3","article-title":"Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?","volume":"67","author":"Conti","year":"2018","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172473_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jcjd.2018.01.008","article-title":"Activated mast cells mediate low-grade inflammation in type 2 diabetes: interleukin-37 could be beneficial","volume":"42","author":"Conti","year":"2018","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.ejphar.2019.172473_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2018.12.004","article-title":"Progression in migraine: role of mast cells and pro-inflammatory and anti-inflammatory cytokines","volume":"844","author":"Conti","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172473_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0378-4274(98)00323-3","article-title":"Cytokines and irritant contact dermatitis","volume":"102\u2013103","author":"Corsini","year":"1998","journal-title":"Toxicol. Lett."},{"issue":"7","key":"10.1016\/j.ejphar.2019.172473_bib14","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1056\/ENEJMicm010831","article-title":"Images in clinical medicine. Systemic mastocytosis","volume":"349","author":"Deb","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172473_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172473_bib16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/eji.201545828","article-title":"Suppression of innate inflammation and immunity by interleukin-37","volume":"46","author":"Dinarello","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2019.172473_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.06.030","article-title":"Targeting c-kit in the therapy of mast cell disorders: current update","volume":"690","author":"El-Agamy","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172473_bib18","first-page":"18","article-title":"Interleukin-1 family cytokines and mast cells: activation and inhibition","volume":"33","author":"Gallenga","year":"2019","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.ejphar.2019.172473_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \"tunable\" effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2019.172473_bib20","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.ejphar.2019.172473_bib21","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.4049\/jimmunol.138.10.3403","article-title":"Human recombinant interleukin 1 beta has no effect on intracellular calcium or on functional responses of human neutrophils","volume":"138","author":"Georgilis","year":"1987","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.ejphar.2019.172473_bib22","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.4049\/jimmunol.140.12.4238","article-title":"IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma","volume":"140","author":"Ghezzi","year":"1988","journal-title":"J. Immunol."},{"issue":"26","key":"10.1016\/j.ejphar.2019.172473_bib23","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2019.172473_bib24","doi-asserted-by":"crossref","first-page":"E1672","DOI":"10.3390\/ijms18081672","article-title":"The effects of selective hematopoietic expression of human IL-37 on systemic inflammation and atherosclerosis in LDLr-deficient mice","volume":"18","author":"Hoeke","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172473_bib25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10875-010-9440-3","article-title":"Molecular mechanism of NLRP3 inflammasome activation","volume":"30","author":"Jin","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"9","key":"10.1016\/j.ejphar.2019.172473_bib26","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.4049\/jimmunol.171.9.4830","article-title":"IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells","volume":"171","author":"Kandere-Grzybowska","year":"2003","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.ejphar.2019.172473_bib27","first-page":"763","article-title":"Impact of mold on mast cell-cytokine immune response","volume":"32","author":"Kritas","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"2","key":"10.1016\/j.ejphar.2019.172473_bib28","first-page":"195","article-title":"Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37","volume":"32","author":"Mastrangelo","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"5","key":"10.1016\/j.ejphar.2019.172473_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10875-017-0399-1","article-title":"Deficiency of interleukin-1 receptor antagonist (DIRA): report of the first Indian patient and a novel deletion affecting IL1RN","volume":"37","author":"Mendonca","year":"2017","journal-title":"J. Clin. Immunol."},{"issue":"3 Suppl. l","key":"10.1016\/j.ejphar.2019.172473_bib30","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J. Investig. Dermatol."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172473_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00011-007-6172-9","article-title":"Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line","volume":"56","author":"Min","year":"2007","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172473_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1751-1097.2012.01182.x","article-title":"Inflammasome activation of IL-1 family mediators in response to cutaneous photodamage","volume":"88","author":"Nasti","year":"2012","journal-title":"Photochem. Photobiol."},{"issue":"4","key":"10.1016\/j.ejphar.2019.172473_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.3103","article-title":"IL-37 requires the receptors IL-18R\u03b1 and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction","volume":"16","author":"Nedoszytko","year":"2015","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172473_bib34","first-page":"84","article-title":"Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis","volume":"31","author":"Nowicki","year":"2014","journal-title":"Postepy Dermatol. Alergol."},{"issue":"3","key":"10.1016\/j.ejphar.2019.172473_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajh.23931","article-title":"Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Pardanani","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.ejphar.2019.172473_bib36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1586\/1744666X.2014.906302","article-title":"Spectrum of mast cell activation disorders","volume":"10","author":"Petra","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.ejphar.2019.172473_bib37","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1440-1746.2012.07187.x","article-title":"Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells","volume":"27","author":"Sakai","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.ejphar.2019.172473_bib38","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/all.12529","article-title":"Update on skin allergy","volume":"69","author":"Schlapbach","year":"2014","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.ejphar.2019.172473_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00281-016-0605-x","article-title":"IL-9-producing cells in the development of IgE-mediated food allergy","volume":"39","author":"Shik","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172473_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/all.12043","article-title":"Do mast cells link obesity and asthma?","volume":"68","author":"Sismanopoulos","year":"2013","journal-title":"Allergy"},{"issue":"40","key":"10.1016\/j.ejphar.2019.172473_bib41","doi-asserted-by":"crossref","first-page":"E9381","DOI":"10.1073\/pnas.1810133115","article-title":"Substance P and IL-33 administered together stimulate a marked secretion of IL-1\u03b2 from human mast cells, inhibited by methoxyluteolin","volume":"115","author":"Taracanova","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172473_bib42","first-page":"13","article-title":"Different signals induce mast cell inflammatory activity: inhibitory effect of Vitamin E","volume":"32","author":"Tettamanti","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"5","key":"10.1016\/j.ejphar.2019.172473_bib43","first-page":"1061","article-title":"IL-33 mediates allergy through mast cell activation: potential inhibitory effect of certain cytokines","volume":"32","author":"Tettamanti","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"5","key":"10.1016\/j.ejphar.2019.172473_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.it.2004.02.013","article-title":"Mast cells: the Jekyll and Hyde of tumor growth","volume":"25","author":"Theoharides","year":"2004","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.ejphar.2019.172473_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2004.09.007","article-title":"Mast cells as targets of corticotropin-releasing factor and related peptides","volume":"25","author":"Theoharides","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2019.172473_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-065X.2007.00519.x","article-title":"Differential release of mast cell mediators and the pathogenesis of inflammation","volume":"217","author":"Theoharides","year":"2007","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.ejphar.2019.172473_bib47","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/1744666X.2019.1596800","article-title":"Recent advances in our understanding of mast cell activation \u2013 or should it be mast cell mediator disorders?","volume":"15","author":"Theoharides","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172473_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejphar.2019.172473_bib49","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-16-2234","article-title":"Advances in the classification and treatment of mastocytosis: current status and outlook toward the future","volume":"77","author":"Valent","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ejphar.2019.172473_bib50","first-page":"1355","article-title":"Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects","volume":"32","author":"Varvara","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"3","key":"10.1016\/j.ejphar.2019.172473_bib51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.iac.2018.04.014","article-title":"New Insights into clonal mast cell disorders including mastocytosis","volume":"38","author":"Volertas","year":"2018","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.ejphar.2019.172473_bib52","article-title":"Mast cell disorders: from infancy to maturity","author":"Wilcock","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.ejphar.2019.172473_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2119\/molmed.2017.00022","article-title":"IL-37 suppresses MyD88-mediated inflammatory responses in human aortic valve interstitial cells","volume":"23","author":"Zhan","year":"2017","journal-title":"Mol. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991930425X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991930425X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:27:56Z","timestamp":1757975276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991930425X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":53,"alternative-id":["S001429991930425X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172473","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insight into systemic mastocytosis mediated by cytokines IL-1\u03b2 and IL-33: Potential inhibitory effect of IL-37","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172473"}}